Back to Treatments

Treatment

Trastuzumab + Chemotherapy (for HER2-positive)

1
Conditions
30
Trials
10K
Participants
35%
Average Safety

Condition Evidence

Stomach cancer

30 trials · 10K participants

85% effectiveness · 35% safety
Trastuzumab + Chemotherapy (for HER2-positive) | DFDA